Free Trial

CreativeOne Wealth LLC Increases Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

UnitedHealth Group logo with Medical background
Remove Ads

CreativeOne Wealth LLC lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 11.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 13,248 shares of the healthcare conglomerate's stock after buying an additional 1,345 shares during the period. CreativeOne Wealth LLC's holdings in UnitedHealth Group were worth $6,702,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the business. Norges Bank purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $6,375,744,000. Raymond James Financial Inc. purchased a new position in UnitedHealth Group during the 4th quarter valued at $1,914,740,000. Amundi increased its stake in UnitedHealth Group by 97.2% in the fourth quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate's stock worth $3,183,132,000 after purchasing an additional 2,991,470 shares during the period. Proficio Capital Partners LLC grew its holdings in shares of UnitedHealth Group by 76,830.4% in the fourth quarter. Proficio Capital Partners LLC now owns 1,888,641 shares of the healthcare conglomerate's stock worth $955,388,000 after purchasing an additional 1,886,186 shares during the last quarter. Finally, Franklin Resources Inc. lifted its holdings in UnitedHealth Group by 10.7% during the 4th quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate's stock valued at $4,514,178,000 after buying an additional 861,854 shares in the last quarter. Institutional investors own 87.86% of the company's stock.

Remove Ads

Analyst Ratings Changes

UNH has been the topic of a number of research reports. Truist Financial raised their target price on shares of UnitedHealth Group from $610.00 to $660.00 and gave the stock a "buy" rating in a research report on Friday. Piper Sandler dropped their price target on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a research report on Thursday, January 2nd. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $700.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Mizuho increased their target price on UnitedHealth Group from $600.00 to $650.00 and gave the company an "outperform" rating in a research report on Wednesday, April 9th. Finally, Barclays decreased their price objective on UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a research note on Friday, January 17th. Twenty-one analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of "Buy" and an average target price of $632.85.

View Our Latest Report on UNH

Insider Activity

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the company's stock in a transaction dated Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now directly owns 4,500 shares of the company's stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 0.33% of the company's stock.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock traded down $3.63 on Tuesday, reaching $583.43. 3,865,335 shares of the stock were exchanged, compared to its average volume of 4,340,638. UnitedHealth Group Incorporated has a twelve month low of $438.50 and a twelve month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm has a market capitalization of $533.67 billion, a price-to-earnings ratio of 37.64, a PEG ratio of 1.37 and a beta of 0.61. The business has a 50 day moving average price of $513.80 and a two-hundred day moving average price of $541.83.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to analysts' expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm's revenue was up 6.8% compared to the same quarter last year. During the same quarter last year, the company posted $5.83 earnings per share. Analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 1.44%. UnitedHealth Group's dividend payout ratio is presently 54.19%.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Recommended Stories

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

5 Stocks to BUY Now as Tariff Uncertainty Fades
WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads